Impact of Positive Family History on the Survival of Breast Cancer
,
Abstract
No Abstract
1. https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
2. Ganggayah MD, Taib NA, Har YC, et al (2019). Predicting factors for survival of breast cancer patients using machine learning techniques. BMC Med Inform Decis Mak, 19(1), 48. Doi: 10.1186/s12911-019-0801-4.
3. Malekzadeh Moghani M, Alahyari S, Moradi A, et al (2021). Pathological Predictors of Response to Neoadjuvant Treatment in Rectal Carcinoma. J Gastrointest Cancer, 52(2):690-695.
4. Chen, Y, Shi, XE, Tian, JH, et al. (2018). Survival benefit of neoadjuvant chemo-therapy for resectable breast cancer: A meta-analysis. Medicine (Baltimore), 97(20),e10634.
5. Yaghobi Joybari A, Behzadi B, Azadeh P, et al (2021). The Outcome of Induction Chemotherapy, Followed by Neoadju-vant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer. Iran J Pathol, 16(3), 266–273.
6. Barnard M, Boeke C, Tamimi R (2015). Es-tablished breast cancer risk factors and the risk of intrinsic tumor subtypes. Bio-chim Biophys Acta, 1856: 73-85.
7. Brewer HR, Jones ME, Schoemaker MJ, et al (2017). Family history and the risk of breast cancer: an analysis of accounting for family structure. Breast Cancer Res Treat, 165 (1): 193-200. doi: 10.1007 / s10549-017-4325-2.
8. Melvin JC, Wulaningsih W, Hana Z et al. (2016). Family history of breast cancer and its association with disease severity and mortality. Cancer Med, 5 (5): 942-949. doi: 10. 1002 / cam4.648.
9. Jobsen JJ, Van der Palen J, Brinkhuis M, et al (2016). Long-term effects of first-degree family history of breast cancer in young women: recurrence and bilateral breast cancer. Acta Oncol, 55 (4): 449-454. doi: 10.3109 / 0284186X.2015.1074281.
2. Ganggayah MD, Taib NA, Har YC, et al (2019). Predicting factors for survival of breast cancer patients using machine learning techniques. BMC Med Inform Decis Mak, 19(1), 48. Doi: 10.1186/s12911-019-0801-4.
3. Malekzadeh Moghani M, Alahyari S, Moradi A, et al (2021). Pathological Predictors of Response to Neoadjuvant Treatment in Rectal Carcinoma. J Gastrointest Cancer, 52(2):690-695.
4. Chen, Y, Shi, XE, Tian, JH, et al. (2018). Survival benefit of neoadjuvant chemo-therapy for resectable breast cancer: A meta-analysis. Medicine (Baltimore), 97(20),e10634.
5. Yaghobi Joybari A, Behzadi B, Azadeh P, et al (2021). The Outcome of Induction Chemotherapy, Followed by Neoadju-vant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer. Iran J Pathol, 16(3), 266–273.
6. Barnard M, Boeke C, Tamimi R (2015). Es-tablished breast cancer risk factors and the risk of intrinsic tumor subtypes. Bio-chim Biophys Acta, 1856: 73-85.
7. Brewer HR, Jones ME, Schoemaker MJ, et al (2017). Family history and the risk of breast cancer: an analysis of accounting for family structure. Breast Cancer Res Treat, 165 (1): 193-200. doi: 10.1007 / s10549-017-4325-2.
8. Melvin JC, Wulaningsih W, Hana Z et al. (2016). Family history of breast cancer and its association with disease severity and mortality. Cancer Med, 5 (5): 942-949. doi: 10. 1002 / cam4.648.
9. Jobsen JJ, Van der Palen J, Brinkhuis M, et al (2016). Long-term effects of first-degree family history of breast cancer in young women: recurrence and bilateral breast cancer. Acta Oncol, 55 (4): 449-454. doi: 10.3109 / 0284186X.2015.1074281.
| Files | ||
| Issue | Vol 51 No 7 (2022) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v51i7.10106 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Malekzadeh Moghani M, Alahyari S, Nasiri M. Impact of Positive Family History on the Survival of Breast Cancer. Iran J Public Health. 2022;51(7):1685-1687.
